THOSE who know of the high profits in pharmaceutical manufacture and trade might be surprised that Government-owned Soviet-aided Indian Drugs and Pharmaceuticals is doing poorly. There are a number of reasons for this. The original Soviet drugs project re-port in the late fifties envisaged a comprehensive programme of manufac-ture from the basic materials down to finished products but, for one thing, several of its more profitable compo-nents were allowed by Government to be fragmented in new foreign-con-trolled units which had easier access to patents (at a price); for another